Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration

Published:2024-08 Issue:8 Volume:8 Page:744-753
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Karkhaneh Reza,Faghihi Hooshang^ORCID,Riazi-Esfahani Hamid^ORCID,Abrishami Mojtaba^ORCID,Bazvand Fatemeh,Ebrahimiadib Nazanin,Johari Mohammadkarim^ORCID,Akhlaghi Mohammadreza,Shoeibi Nasser^ORCID,Norouzzadeh Mohammad Hossein,Ansari Astaneh Mohammad Reza,Khojasteh Hassan,Imani Fooladi Marjan,Khodabande Alireza,Ghassemi Fariba,Khalili Pour Elias^ORCID,Zarei Mohammad^ORCID,Mirshahi Ahmad,Fazel Farhad,Ashraf Hossein^ORCID,Hosseini Seyedeh Maryam^ORCID,Dourandeesh Maryam^ORCID,Feghhi Mostafa,Alizadeh Yousef,Behboudi Hassan,Azadi Pejvak,Sabzvari Araz,Kafi Hamidreza,Ghasemi Falavarjani Khalil^ORCID

Funder

CinnaGen Co

Publisher

Elsevier BV

Reference22 articles.

1. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA);Schmidt-Erfurth;Br J Ophthalmol,2014

2. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N Engl J Med,1994

3. Management of neovascular age-related macular degeneration: a review on landmark randomized controlled trials;Agarwal;Middle East Afr J Ophthalmol,2016

4. Ocular neovascularization: basic mechanisms and therapeutic advances;Dorrell;Surv Ophthalmol,2007

5. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration;Heier;Ophthalmology,2012